Universal Nerve Block Tray Recalled Due to Manufacturing Test Validation Uncertainty
Busse Hospital Disposables recalls Universal Nerve Block Trays and swab products manufactured by PDI due to uncertainty regarding manufacturing test method validation.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II precautionary recall due to manufacturing test method validation concerns. The hazard is theoretical, based on manufacturing process uncertainty rather than a known contamination or defect.
Plain-English summary
Busse Hospital Disposables, Inc. is recalling Universal Nerve Block Trays (Catalog Number 9818) that contain swab and swabstick drug products manufactured by Professional Disposables International (PDI). Sixty units were distributed nationwide, with affected lot numbers 2030783, 2031093, 2130287, 2130412, 2130681, and 2131043.
The recall was initiated due to uncertainty regarding the adequacy of validation of the test methods used to manufacture the drug products.
Healthcare providers and facilities that have received these products should contact Busse Hospital Disposables, Inc. for instructions regarding this recall.
The recalled product
- Product
- Universal Nerve Block Tray Catalog Number: 9818
- Manufacturer
- Busse Hospital Disposables, Inc.
- Category
- Drug — Medical / Swabs
- Hazard
- manufacturing-validation
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27